03.26.21

Gyroscope Therapeutics Announces $148 Million Raised in Series C Financing

Source: Gyroscope Therapeutics

02.12.21

Gyroscope Therapeutics Announces Positive Interim Data from Phase 1 FOCUS Trial of Investigational Gene Therapy GT005

Source: Gyroscope Therapeutics

12.17.20

Wolfe Eye Clinic Performs First Surgery in Clinical Trial Evaluating an Investigational Gene Therapy for Geographic Atrophy Secondary to Dry AMD

Source: Wolfe Eye Clinic

11.11.20

Gyroscope Therapeutics Announces First Patient Dosed in Phase 2 Trial Evaluating Investigational Gene Therapy for Dry AMD

Source: Gyroscope Therapeutics

10.30.20

Gyroscope Therapeutics Announces First Patient Received Investigational Gene Therapy for Dry AMD Via Orbit SDS

Source: Gyroscope Therapeutics

09.22.20

Gyroscope Therapeutics Granted FDA Fast Track Designation for Investigational Gene Therapy for Dry AMD

Source: Gyroscope Therapeutics

08.13.20

Gyroscope Therapeutics Initiates Phase 2 Program Evaluating its Investigational Gene Therapy for Dry AMD

Source: Gyroscope Therapeutics

View more stories